APPLICATION
ANDA078359
TYPE
ANDA
ORIGINAL APPROVAL
2010-11-16
LATEST ACTION
2019-10-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DESLORATADINEDiscontinued
DESLORATADINE 5MG · TABLET · ORAL
Approval history
2019-10-22Labeling · Supplement 3 · standardAP
2019-10-22Labeling · Supplement 8 · standardAP
2013-10-07Labeling · Supplement 1 · standardAP
2010-11-16OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.